BeOne Medicines
ONC
#653
Rank
$38.97 B
Marketcap
$352.23
Share price
-4.54%
Change (1 day)
35.63%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Sustainability Reports

Thumbnail BeOne Medicines Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail BeOne Medicines Sustainability Report 2020

Sustainability Report 2020

Language: English

View Sustainability Report